Carbamazepine chemical structure
Find information on thousands of medical conditions and prescription drugs.

Carbamazepine

Carbamazepine (sold under the brand-names Biston®, Calepsin®, Carbatrol®, Epitol®, Equetro®, Finlepsin®, Sirtal®, Stazepine®, Tegretol®, Telesmin®, Timonil®) is an anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy and bipolar disorder. It is also used to treat schizophrenia and trigeminal neuralgia. more...

Home
Diseases
Medicines
A
B
C
Cabergoline
Caduet
Cafergot
Caffeine
Calan
Calciparine
Calcitonin
Calcitriol
Calcium folinate
Campath
Camptosar
Camptosar
Cancidas
Candesartan
Cannabinol
Capecitabine
Capoten
Captohexal
Captopril
Carbachol
Carbadox
Carbamazepine
Carbatrol
Carbenicillin
Carbidopa
Carbimazole
Carboplatin
Cardinorm
Cardiolite
Cardizem
Cardura
Carfentanil
Carisoprodol
Carnitine
Carvedilol
Casodex
Cataflam
Catapres
Cathine
Cathinone
Caverject
Ceclor
Cefacetrile
Cefaclor
Cefaclor
Cefadroxil
Cefazolin
Cefepime
Cefixime
Cefotan
Cefotaxime
Cefotetan
Cefpodoxime
Cefprozil
Ceftazidime
Ceftriaxone
Ceftriaxone
Cefuroxime
Cefuroxime
Cefzil
Celebrex
Celexa
Cellcept
Cephalexin
Cerebyx
Cerivastatin
Cerumenex
Cetirizine
Cetrimide
Chenodeoxycholic acid
Chloralose
Chlorambucil
Chloramphenicol
Chlordiazepoxide
Chlorhexidine
Chloropyramine
Chloroquine
Chloroxylenol
Chlorphenamine
Chlorpromazine
Chlorpropamide
Chlorprothixene
Chlortalidone
Chlortetracycline
Cholac
Cholybar
Choriogonadotropin alfa
Chorionic gonadotropin
Chymotrypsin
Cialis
Ciclopirox
Cicloral
Ciclosporin
Cidofovir
Ciglitazone
Cilastatin
Cilostazol
Cimehexal
Cimetidine
Cinchophen
Cinnarizine
Cipro
Ciprofloxacin
Cisapride
Cisplatin
Citalopram
Citicoline
Cladribine
Clamoxyquine
Clarinex
Clarithromycin
Claritin
Clavulanic acid
Clemastine
Clenbuterol
Climara
Clindamycin
Clioquinol
Clobazam
Clobetasol
Clofazimine
Clomhexal
Clomid
Clomifene
Clomipramine
Clonazepam
Clonidine
Clopidogrel
Clotrimazole
Cloxacillin
Clozapine
Clozaril
Cocarboxylase
Cogentin
Colistin
Colyte
Combivent
Commit
Compazine
Concerta
Copaxone
Cordarone
Coreg
Corgard
Corticotropin
Cortisone
Cotinine
Cotrim
Coumadin
Cozaar
Crestor
Crospovidone
Cuprimine
Cyanocobalamin
Cyclessa
Cyclizine
Cyclobenzaprine
Cyclopentolate
Cyclophosphamide
Cyclopropane
Cylert
Cyproterone
Cystagon
Cysteine
Cytarabine
Cytotec
Cytovene
Isotretinoin
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Mechanisms

Carbamazepine and its derivatives' action mechanism is not well understood, but appears to be primarily through the inhibition of sodium channel activity.

Side-effects

Carbamazepine renders birth control pills ineffective.

Common side-effects include drowsiness, motor-coordination impairment and/or upset stomach. Taken every twelve hours, the Tegretol XR® or Carbatrol® preparations can greatly increase tolerability.

Less common side-effects include blurry or double vision and/or the temporary or mild loss of blood cells or platelets. In rare cases the latter can be life-threatening if unnoticed, so frequent blood tests are required during the first few months' use, followed by three or four tests per year. There are also reports of a bizarre auditory side-effect, whereby patients perceive musical notes about a semitone lower than their actual pitch (so middle C would be heard as the note B3 just below it, etc).

Oxcarbazepine, a derivative of carbamazepine, has fewer and less serious side-effects.

History

Carbamazepine was discovered by chemist Walter Schindler at J.R. Geigy AG (now part of Novartis) in Basel, Switzerland, in 1953. Schindler then synthesized the drug in 1960, before its anti-epileptic properties had been discovered.

Carbamazepine was first marketed as a drug to treat trigeminal neuralgia in 1962. It has been used as an anticonvulsant in the UK since 1965, but only approved in the U.S. since 1974.

Read more at Wikipedia.org


[List your site here Free!]


Evidence-based guidelines for bipolar disorder therapy
From American Family Physician, 1/1/05 by Anne D. Walling

Many patients with depression are now recognized as having bipolar disorder, a chronic biphasic mood disorder with episodes of both depression and mania or hypomania. Successful management of bipolar disorder requires suppression of acute mania, treatment of acute depression, and prevention of relapse into either condition. No single medication can achieve all of these objectives. McIntyre and colleagues examined evidence supporting the efficacy of each of the medications commonly used to treat bipolar disorder. Their review article stresses the need for individualization of therapy and adaptation to the changing needs of each patient over time.

Lithium was the earliest mood-stabilizing medication and still is used extensively. The efficacy of lithium is well established in patients who are in manic states, and it is known to reduce the rates of suicide. Lithium is most effective in patients who have little comorbidity and do not cycle rapidly. Patients who are likely not to respond well to lithium include those with frequent previous episodes, rapid cycling, depressive and anxious symptoms during the manic phase, substance abuse, and medical conditions.

The second-generation antiepileptic drugs divalproex and carbamazepine are highly effective in patients with acute mania, but have less effect in patients with depression and in the prevention of symptom recurrence. These drugs are useful in patients who do not respond to lithium, but their use is limited by side effects such as weight gain and sedation, as well as multiple drug-drug interactions and the need to monitor blood levels of the drug along with hepatic and hematologic indexes.

Conversely, the third-generation antiepileptic drug lamotrigine is effective in the treatment of depression and the prevention of recurrence, and does not require blood monitoring. The major problem with lamotrigine is a rash that develops in up to 10 percent of patients and can progress to Stevens-Johnson syndrome. Fewer data are available about other third-generation antiepileptic drugs. Gabapentin is useful for anxiety symptoms, and topiramate may improve depressive states. Oxcarbazepine may provide many of the antimania and antidepressant effects of carbamazepine with fewer side effects and drug interactions.

The conventional antipsychotic agents, such as haloperidol, have been used to treat acute mania, but their use is limited by dysphoria, tardive dyskinesia, and extrapy-ramidal effects. The novel antipsychotics, such as olanzapine, risperidone, and quetiapine, have direct antidepressant effects and are highly effective against mania. These actions appear to be independent of the anti-psychotic effects of these drugs, and most bipolar patients benefit at low dosages (e.g., 10 to 15 mg of olanzapine, 2 to 4 mg of risperidone, 400 to 800 mg of quetiapine). This group of drugs may be particularly effective as adjunctive therapy with antidepressants in patients with bipolar depression and in maintenance therapy, when combined with lithium or divalproex. The biggest disadvantage of the novel antipsychotics is weight gain; lipid and glucose abnormalities also occur.

Although evidence is limited, antidepressants are commonly used for short periods (up to two months) to treat patients in the depressed phase of bipolar disorder. The danger of precipitating mania is reported to be greatest with tricyclic agents.

The authors conclude that a combination of medical and psychosocial strategies is required for successful treatment of bipolar disorder. Patients frequently have problems adhering to therapy and require education and assistance with lifestyle issues to cope with this lifelong condition.

McIntyre RS, et al. Treating bipolar disorder. Evidence-based guidelines for family medicine. Can Fam Physician March 2004;50:388-94.

COPYRIGHT 2005 American Academy of Family Physicians
COPYRIGHT 2005 Gale Group

Return to Carbamazepine
Home Contact Resources Exchange Links ebay